Toshihiko Doi

34PUBLICATIONS
157CO-AUTHORS
Molecular targetsPharmacogenomicsMicrobial geneticsGene and molecular therapyTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Mar 23, 2026
Zanidatamab, a Dual HER2-Targeted Bispecific Antibody, in Patients with Unresectable Locally Advanced or Metastatic HER2-Positive Salivary Gland Cancer: A Combined Analysis of Early-Phase Studies.

Keun-Wook Lee, Elena Elimova, Do-Youn Oh

|Mar 01, 2026
Study protocol for a phase I investigator-initiated clinical trial of E7820 in Japanese patients with unresectable solid tumours: CIRCUS trial (NCCH2303).

Mao Okada, Jun Sato, Chikako Funasaka

|Dec 29, 2025
Erdafitinib in Patients with FGFR-Altered Advanced or Metastatic Cholangiocarcinoma.

Shubham Pant, Joon Oh Park, Wu-Chou Su

|Nov 20, 2025
Pooled safety analysis of pimitespib for the treatment of patients with advanced gastrointestinal stromal tumors.

Yukinori Kurokawa, Noboru Yamamoto, Yuko Hirano

|Jul 14, 2025
Microbiota-driven antitumour immunity mediated by dendritic cell migration.

Nina Yi-Tzu Lin, Shota Fukuoka, Shohei Koyama

|Feb 20, 2025
Pembrolizumab in microsatellite-instability-high and mismatch-repair-deficient advanced solid tumors: updated results of the KEYNOTE-158 trial.

Aurelien Marabelle, David M O'Malley, Andrew E Hendifar

Pageof 6

Frequent Collaborators

4 joint publications

Yasutoshi Kuboki

4 joint publications

Kohei Shitara

3 joint publications

Hideaki Bando

3 joint publications

Hiroyoshi Nishikawa